Matthew M Nour,Lisa Evans,Robin L Carhart-Harris
Matthew M Nour
The psychedelic experience (including psychedelic-induced ego dissolution) can effect lasting change in a person's attitudes and beliefs. Here, we aimed to investigate the association between naturalistic psychedelic use and personality, po...
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up [0.03%]
关于JWH-122摄入的不良影响的一个持续性视觉异常五年随访病例报告
Maurizio Coppola,Raffaella Mondola
Maurizio Coppola
Synthetic cannabinoid receptor agonists are a heterogeneous group of psychotropic drugs functionally related to Δ9-tetrahydrocannabinol. These substances, marketed as cannabis substitutes, have been associated with numerous cases of severe...
Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System [0.03%]
《平价医疗法案》后整合型卫生保健系统中布施普品那治疗与患者使用医疗服务的关系
Cynthia I Campbell,Sujaya Parthasarathy,Kelly C Young-Wolff et al.
Cynthia I Campbell et al.
The Affordable Care Act (ACA) was expected to benefit patients with substance use disorders, including opioid use disorders (OUDs). This study examined buprenorphine use and health services utilization by patients with OUDs pre- and post-AC...
Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders [0.03%]
美国平价医疗法案的保险收据和机遇准备情况——一份针对物质使用障碍治疗提供者的全国调查
Lydia Aletraris,Mary Bond Edmond,Paul M Roman
Lydia Aletraris
This study measures the readiness of substance use disorder (SUD) treatment to use opportunities under the Affordable Care Act by examining Medicaid and private insurance acceptance between 2011 and 2013, as well as center characteristics a...
Motivations for Using MDMA (Ecstasy/Molly) among African Americans: Implications for Prevention and Harm-Reduction Programs [0.03%]
美国非裔人群使用MDMA（摇头丸/慕丽）的动机以及对预防和减少伤害项目的启示
Khary K Rigg
Khary K Rigg
Despite the growing popularity of MDMA (ecstasy/molly) among African Americans, their motives for using the drug are still largely unknown. The purpose of this study was to identify and describe the most salient motivations for using MDMA a...
Massachusetts Substance Use Disorder Treatment Organizations' Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design [0.03%]
美国马萨诸塞州物质使用障碍治疗组织对《平价医疗法案》的看法：支付方式、服务和系统设计的变化
Amity E Quinn,Maureen T Stewart,Mary Brolin et al.
Amity E Quinn et al.
The Affordable Care Act (ACA) expanded insurance benefits and coverage for substance use disorder (SUD) treatment and encouraged delivery and payment reforms. Massachusetts passed a similar reform in 2006. This study aims to assess Massachu...
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014 [0.03%]
美国商业健康保险计划中针对阿片类药物使用障碍的特定治疗方法的报销情况（2003-2014）
Sharon Reif,Timothy B Creedon,Constance M Horgan et al.
Sharon Reif et al.
Opioid use disorders (OUDs) are receiving significant attention in the U.S. as a public health crisis. Access to treatment for OUDs is essential and was expected to improve following implementation of the federal parity law and the Affordab...
Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders [0.03%]
平价医疗法案执行中的治疗整合：一项全国范围内的物质使用障碍治疗机构服务变化调查研究
Lydia Aletraris,Paul M Roman,Jana Pruett
Lydia Aletraris
This study examined patterns of medicalization in substance use disorder (SUD) that are aligned with the goals of the Affordable Care Act (ACA). Using a nationally representative sample of SUD treatment programs, we examined changes in seve...
Relationships between a Dissociative Subtype of PTSD and Clinical Characteristics in Patients with Substance Use Disorders [0.03%]
substance use障碍患者中PTSD分离亚型与其临床特征的关系
Michaela Mergler,Martin Driessen,Christel Lüdecke et al.
Michaela Mergler et al.
The increasing support for a dissociative subtype of post-traumatic stress disorder (PTSD-D) has led to its inclusion in DSM-5. We examined relationships between PTSD-D and relevant variables in patients with substance use disorders (SUD). ...
The Addiction Benefits Scorecard: A Framework to Promote Health Insurer Accountability and Support Consumer Engagement [0.03%]
依赖益处记分牌：促进健康保险商承担责任和消费者参与的框架
Itai Danovitch,David Kan
Itai Danovitch
Health care insurance plans covering treatment for substance use disorders (SUD) offer a wide range of benefits. Distinctions between health plan benefits are confusing, and consumers making selections may not adequately understand the char...